These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 6854339)
1. Mammalian drug metabolism. Nelson SD; Gordon WP J Nat Prod; 1983 Jan; 46(1):71-8. PubMed ID: 6854339 [TBL] [Abstract][Full Text] [Related]
2. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran. Gordon WP; Huitric AC; Seth CL; McClanahan RH; Nelson SD Drug Metab Dispos; 1987; 15(5):589-94. PubMed ID: 2891472 [TBL] [Abstract][Full Text] [Related]
3. Hepatotoxicity and pulmonary toxicity of pennyroyal oil and its constituent terpenes in the mouse. Gordon WP; Forte AJ; McMurtry RJ; Gal J; Nelson SD Toxicol Appl Pharmacol; 1982 Sep; 65(3):413-24. PubMed ID: 7157374 [No Abstract] [Full Text] [Related]
4. A decades-long investigation of acute metabolism-based hepatotoxicity by herbal constituents: a case study of pennyroyal oil. Gordon P; Khojasteh SC Drug Metab Rev; 2015 Feb; 47(1):12-20. PubMed ID: 25512112 [TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of drug metabolism--implications for drug interaction]. Sitkiewicz D Pol Merkur Lekarski; 2000 Sep; 9(51):595-7. PubMed ID: 11126981 [TBL] [Abstract][Full Text] [Related]
6. Mitigation of pennyroyal oil hepatotoxicity in the mouse. Sztajnkrycer MD; Otten EJ; Bond GR; Lindsell CJ; Goetz RJ Acad Emerg Med; 2003 Oct; 10(10):1024-8. PubMed ID: 14525732 [TBL] [Abstract][Full Text] [Related]
7. Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation. Riches Z; Bloomer J; Patel A; Nolan A; Coughtrie M Xenobiotica; 2009 May; 39(5):374-81. PubMed ID: 19280384 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide. Khojasteh-Bakht SC; Chen W; Koenigs LL; Peter RM; Nelson SD Drug Metab Dispos; 1999 May; 27(5):574-80. PubMed ID: 10220485 [TBL] [Abstract][Full Text] [Related]
9. Carbon-carbon bond cleavage and formation reactions in drug metabolism and the role of metabolic enzymes. Bolleddula J; Chowdhury SK Drug Metab Rev; 2015; 47(4):534-57. PubMed ID: 26390887 [TBL] [Abstract][Full Text] [Related]
10. Enzymatic activation of chemicals to toxic metabolites. Guengerich FP; Liebler DC Crit Rev Toxicol; 1985; 14(3):259-307. PubMed ID: 3926381 [TBL] [Abstract][Full Text] [Related]
11. "Boldly they rode ... into the mouth of hell". Pennyroyal oil toxicity. Mack RB N C Med J; 1997; 58(6):456-7. PubMed ID: 9392962 [No Abstract] [Full Text] [Related]
12. [Metabolism of drugs. I. Basic metabolic reactions]. Dyderski S; Grzymisławski M Pol Merkur Lekarski; 2005 Apr; 18(106):446-52. PubMed ID: 16161932 [TBL] [Abstract][Full Text] [Related]
13. A Novel In Vitro Experimental System for the Evaluation of Drug Metabolism: Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Cryopreserved Human Hepatocytes). Li AP; Ho MD; Amaral K; Loretz C Drug Metab Dispos; 2018 Nov; 46(11):1608-1616. PubMed ID: 29363498 [TBL] [Abstract][Full Text] [Related]
14. Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Zamek-Gliszczynski MJ; Hoffmaster KA; Nezasa K; Tallman MN; Brouwer KL Eur J Pharm Sci; 2006 Apr; 27(5):447-86. PubMed ID: 16472997 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of (R)-(+)-pulegone in F344 rats. Chen LJ; Lebetkin EH; Burka LT Drug Metab Dispos; 2001 Dec; 29(12):1567-77. PubMed ID: 11717176 [TBL] [Abstract][Full Text] [Related]
16. The biochemistry of drug metabolism--an introduction: part 4. reactions of conjugation and their enzymes. Testa B; Krämer SD Chem Biodivers; 2008 Nov; 5(11):2171-336. PubMed ID: 19035562 [TBL] [Abstract][Full Text] [Related]
17. Drug metabolism and toxicity during hypoxia. Jones DP; Aw TY; Shan XQ Drug Metab Rev; 1989; 20(2-4):247-60. PubMed ID: 2680383 [TBL] [Abstract][Full Text] [Related]
18. Phase II enzymes and bioactivation. Hinson JA; Forkert PG Can J Physiol Pharmacol; 1995 Oct; 73(10):1407-13. PubMed ID: 8748931 [TBL] [Abstract][Full Text] [Related]
19. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione. Thomassen D; Slattery JT; Nelson SD J Pharmacol Exp Ther; 1990 May; 253(2):567-72. PubMed ID: 2338648 [TBL] [Abstract][Full Text] [Related]
20. Effects of model traumatic injury on hepatic drug metabolism in the rat. V. Sulfation and acetylation. Griffeth LK; Rosen GM; Rauckman EJ Drug Metab Dispos; 1985; 13(4):398-405. PubMed ID: 2863101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]